Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 315 participants.
Also called NCT04135287
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 315 participants
- Sponsor
- Dasman Diabetes Institute
- Registry
-
NCT04135287
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Kuwait
- Registry status
- Unknown status
Technical summary
Registry record NCT04135287. Allocation not applicable; no masking; primary purpose treatment. Start 2020-03-01 (actual); primary completion 2023-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- GLP-1 receptor agonist
- Lead sponsor
- Dasman Diabetes Institute
Record details
- Record id
cardio:ct-nct04135287- Content hash
fbea3c5c87ac8e14b15ea3efe5d95a77fba34de7d6db3038321f97ed889d66a1